Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.67 is 49% above its 5-year average of -1.31, near the high end of its 5-year range (-2.54–0.00).
50.74% above its 12-month average of -1.36.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:36:11.714Z. Historical observations retain their original dates. Historical series through 2022-03-31.
EARNINGS PER SHARE (EPS)
-0.67
EARNINGS PER SHARE (EPS) AVG TTM
-1.36
EARNINGS PER SHARE (EPS) AVG 3Y
-1.71
EARNINGS PER SHARE (EPS) AVG 5Y
-1.31
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.74%
CURRENT VS 3Y AVG
+60.76%
CURRENT VS 5Y AVG
+48.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Envoy Medical, Inc.
Market Cap
$51.03M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$51.39M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$51.45M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$51.18M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$51.27M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.51
3Y Avg
-0.97
5Y Avg
-1.13
Market Cap
$51.98M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$50.47M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$51.99M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.43
3Y Avg
-2.38
5Y Avg
-2.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Envoy Medical, Inc. (COCH) | $51.03M | -0.67 | -1.36 | -1.71 | -1.31 |
| Apollomics, Inc. (APLM)vs › | $51.39M | N/A | -30.18 | -88.49 | -66.35 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.45M | -8.95 | -8.42 | -12.89 | -25.33 |
| INmune Bio, Inc. (INMB)vs › | $51.18M | -0.69 | -1.98 | -1.79 | -1.67 |
| biote Corp. (BTMD)vs › | $51.83M | 0.12 | 0.48 | 0.24 | 1.52 |
| Microbot Medical Inc. (MBOT)vs › | $51.27M | -0.26 | -0.51 | -0.97 | -1.13 |
| eXoZymes, Inc. (EXOZ)vs › | $51.98M | -1.20 | -0.91 | -0.56 | -0.48 |
| Clene Inc. (CLNN)vs › | $50.47M | -3.55 | -4.16 | -5.92 | -5.28 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.99M | -1.00 | -1.43 | -2.38 | -2.90 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.91M | N/A | -7.29 | -67.66 | -178.24 |
Trailing EPS (TTM)
$-0.67
Forward EPS (Est.)
$-0.29
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.23 |
| 2024-12-31 | -1.49 |
| 2023-12-31 | -2.54 |
| 2022-12-31 | -1.57 |
| 2021-12-31 | -1.05 |
| 2020-12-31 | 0.00 |
